Vijayakrishna Gadi, PhD, MD

University of Illinois Cancer Center

Professor of Medicine and Director of Medical Oncology in the Division of Hematology and Oncology at the University of Illinois College of Medicine, and Deputy Director of the University of Illinois Cancer Center.

Published Articles (1)

ASCENT-03, ASCENT-04, and Dato-DXd: How ADCs Are Replacing Chemotherapy in Metastatic TNBC

June 10, 2026

ADCs are now first-line options in metastatic TNBC regardless of PD-L1 status. Dr. VK Gadi breaks down ASCENT-03, ASCENT-04, and Dato-DXd—and what's coming next in a rapidly shifting treatment landscape.